Manhattan Scientifics, Inc., together with its subsidiaries, focuses on the technology transfer and commercialization of disruptive technologies in the nano medicine space in the United States. The Company is developing commercial medical prosthetics applications for its ultra-fine grain metals; and plans to commercialize the cancer research work and nano medical applications.